Paxmedica, inc. announces third quarter 2023 financial results and business update

Tarrytown, ny / accesswire / november 15, 2023 / paxmedica, inc. (nasdaq:pxmd), a biopharmaceutical company focused on advancing treatments for neurological disorders, announced today a comprehensive business update along with its financial results for the third quarter ended september 30, 2023. key updates and achievements successfully concluded a crucial fda type-b meeting, gathering vital guidance for the nda submission of pax-101.
PXMD Ratings Summary
PXMD Quant Ranking